List was last updated on
.-
- Diagnosis, Management, and Surveillance for Patients with PALB2, CHEK2, and ATM Gene Mutations.
- Fencer MG, Krupa KA, Bleich GC, Grumet S, Eladoumikdachi FG, Kumar S, Kowzun MJ, Potdevin LB.
- Clin Breast Cancer. 2023 Feb 15:S1526-8209(23)00034-4. doi: 10.1016/j.clbc.2023.02.004. Epub ahead of print.
-
- Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography.
- Dietzel F, Kolberg L, Vesper AS, Hoffmann J, Nestle-Krämling C, Zwiefel K, Friebe V, Sawicki LM, Bruckmann NM, Jannusch K, Morawitz J, Antoch G, Fehm TN, Kirchner J, Mohrmann S.
- Cancers (Basel). 2023 Jan 29;15(3):829. doi: 10.3390/cancers15030829.
-
- Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy.
- Fasano GA, Bayard S, Chen Y, Marti J, Simmons R, Swistel A, Bensenhaver J, Davis M, Newman L.
- Ann Surg Oncol. 2023 Jan 21. doi: 10.1245/s10434-022-13056-0. Epub ahead of print.
- PMID: 36681737
- PubMed abstract
- Source abstract
-
- Factors that influence the management recommendations breast surgeons provide to women with pathogenic variants in moderate penetrance breast cancer susceptibility genes.
- Vanderwal A, Lewis J, Basil J, Atzinger C, Widmeyer K.
- J Genet Couns. 2023 Jan 15. doi: 10.1002/jgc4.1674. Epub ahead of print.
- PMID: 36642783
- PubMed abstract
- Source abstract
-
- Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.
- Makhnoon S, Gutierrez Barrera AM, Bassett R, Afrough A, Bedrosian I, Arun BK.
- Breast J. 2022 Dec 31. doi: 10.1155/2022/1447545. Online ahead of print.
-
- Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.
- Maksimenko J, Rodrigues PP, Nakazawa-Miklaševiča M, Pinto D, Miklaševičs E, Trofimovičs G, Gardovskis J, Cardoso F, Cardoso MJ.
- JMIR Form Res. 2022 Dec 29;6(12):e37144. doi: 10.2196/37144.
- PMID: 36580360
- PubMed abstract
-
- Postmastectomy breast reconstruction for women with hereditary gastric and breast cancer syndrome.
- De Lorenzi F, Borelli F, Catapano S, Alessandri-Bonetti M, Sala P, Veronesi P.
- Eur J Cancer Prev. 2022 Dec 27. doi: 10.1097/CEJ.0000000000000780. Epub ahead of print.
- PMID: 36574282
- PubMed abstract
- Source abstract
-
- All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits.
- Wu HL, Luo ZY, He ZL, Gong Y, Mo M, Ming WK, Liu GY.
- Br J Cancer. 2022 Dec 23. doi: 10.1038/s41416-022-02111-y. Epub ahead of print.
- PMID: 36564566
- PubMed abstract
-
- Is Sentinel Lymph Node Biopsy Necessary in Patients who Undergo Prophylactic Mastectomy?
- Madan V, Mamounas EP.
- Clin Breast Cancer. 2022 Dec 7:S1526-8209(22)00271-3. doi: 10.1016/j.clbc.2022.12.003. Epub ahead of print.
-
- Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?
- Ain Q, Richardson C, Mutebi M, George A, Kemp Z, Rusby JE.
- Breast. 2022 Dec 6:S0960-9776(22)00193-X. doi: 10.1016/j.breast.2022.12.001. Epub ahead of print.
-
- Nonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer.
- Evron E, Ben-David MA, Kaidar-Person O, Corn BW.
- J Clin Oncol. 2022 Oct 28:JCO2201609. doi: 10.1200/JCO.22.01609. Epub ahead of print.
- PMID: 36306484
- PubMed abstract
- Source abstract
- Commentary
- Free Full Text
-
- PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.
- Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BAM, Becher H, Blomqvist C, Bojesen SE, Bolla MK, Camp NJ, Czene K, Devilee P, Eccles DM, Fasching PA, Figueroa JD, Flyger H, García-Closas M, Haiman CA, Hamann U, Hopper JL, Jakubowska A, Leeuwen FE, Lindblom A, Lubinski J, Margolin S, Martinez ME, Nevanlinna H, Nevelsteen I, Pelders S, Pharoah PDP, Siesling S, Southey MC, van der Hout AH, van Hest LP, Chang-Claude J, Hall P, Easton DF, Steyerberg EW, Schmidt MK.
- Breast Cancer Res. 2022 Oct 21;24(1):69. doi: 10.1186/s13058-022-01567-3.
- PMID: 36271417
- PubMed abstract
-
- Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
- Wong SM, Ferroum A, Apostolova C, Alhassan B, Prakash I, Basik M, Boileau JF, Meterissian S, Aleynikova O, Wong N, Foulkes WD.
- Ann Surg Oncol. 2022 Oct;29(11):6660-6668. doi: 10.1245/s10434-022-11916-3. Epub 2022 May 26.
- PMID: 35616744
- PubMed abstract
- Source abstract
-
- Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer.
- Corso G, Magnoni F, Veronesi P.
- Ann Surg Oncol. 2022 Sep 15. doi: 10.1245/s10434-022-12542-9. Epub ahead of print.
- PMID: 36109411
- PubMed abstract
- Source abstract
-
- Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations.
- Thompson JL, Sinco BR, McCaffrey RL, Chang AE, Sabel MS, Dossett LA, Hughes TM, Jeruss JS.
- J Surg Oncol. 2022 Sep 7. doi: 10.1002/jso.27088. Epub ahead of print.
- PMID: 36069388
- PubMed abstract
- Source abstract
-
- Eligibility, uptake and response to germline genetic testing in women with DCIS.
- Turza L, Lovejoy LA, Turner CE, Shriver CD, Ellsworth RE.
- Front Oncol. 2022 Aug 26;12:918757. doi: 10.3389/fonc.2022.918757.
- PMID: 36091166
- PubMed abstract
-
- Influence of germline test results on surgical decision making in women with invasive breast cancer.
- Vargason AB, Turner CE, Shriver CD, Ellsworth RE.
- Cancer Genet. 2022 Aug;266-267:81-85. doi: 10.1016/j.cancergen.2022.07.003. Epub 2022 Jul 13.
- PMID:35868102
- PubMed abstract
- Source abstract
-
- Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire.
- Herold N, Hellmich M, Lichtenheldt F, Ataseven B, Hillebrand V, Wappenschmidt B, Schmutzler RK, Rhiem K.
- Genes (Basel). 2022 Jul 28;13(8):1357. doi: 10.3390/genes13081357.
- PMID: 36011268
- PubMed abstract
- Source abstract
-
- Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer.
- Ro V, McGuinness JE, Guo B, Trivedi MS, Jones T, Chung WK, Rao R, Levinson E, Koval C, Russo D, Chilton I, Kukafka R, Crew KD.
- JCO Oncol Pract. 2022 Apr;18(4):e472-e483. doi: 10.1200/OP.21.00322. Epub 2021 Oct 27.
- PMID: 34705516
- PubMed abstract
- Source abstract
-
- Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers.
- Sandoval RL, Polidorio N, Leite ACR, Cartaxo M, Pisani JP, Quirino CV, Cezana L, Pereira NG, Pereira AAL, Rossi BM, Achatz MI.
- Front Oncol. 2022 Mar 16;12:836937. doi: 10.3389/fonc.2022.836937.
- PMID: 35371985
- PubMed abstract
-
- Surgery and prophylactic surgery in hereditary breast cancer.
- Morrow M.
- Breast. 2022 Mar;62 Suppl 1:S63-S66. doi: 10.1016/j.breast.2021.12.010. Epub 2021 Dec 13.
- PMID: 34924253
- PubMed abstract
- Review
- Free Full Text
-
- Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis.
- Wang C, Lin Y, Zhu H, Zhou Y, Mao F, Huang X, Zhou X, Cao X, Sun Q.
- Breast Cancer. 2022 Mar;29(2):314-323. doi: 10.1007/s12282-021-01312-2. Epub 2021 Nov 11.
- PMID: 34766244
- PubMed abstract
- Source abstract
-
- Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observation.
- Pitiyarachchi O, Phillips KA, Friedlander M.
- Cancer Treat Res Commun. 2022 Jan 1;30:100504. doi: 10.1016/j.ctarc.2021.100504. Epub ahead of print.
- PMID: 34990902
- PubMed abstract
- Case report
- Free Full Text
-
- Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li-Fraumeni syndrome.
- Siegel A, Bremer RC, Klein WMP, Savage SA, Loud JT, Khincha PP.
- Breast Cancer Res Treat. 2022 Jan;191(1):159-167. doi: 10.1007/s10549-021-06410-5. Epub 2021 Oct 15.
- PMID: 34652547
- PubMed abstract
- Source abstract
-
- Is there an increasing trend of risk-reducing prophylactic mastectomy procedure in preventing breast cancer among women?
- Arslan B, Tazeoglu D, Dag A, Berkesoglu M, Özdemir AA.
- Turk J Surg. 2021 Dec 31;37(4):347-354. doi: 10.47717/turkjsurg.2021.4963.
- PMID: 35677477
- PubMed abstract
- Source abstract
-
- Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries.
- Moukadem HA, Al Masry A, Atwani RW, Kreidieh F, Khalil LE, Saroufim R, Daouk S, Dalle IA, El Saghir NS.
- Eur J Breast Health. 2021 Dec 30;18(1):16-20. doi: 10.4274/ejbh.galenos.2021.2021-5-1.
- PMID: 35059587
- PubMed abstract
- Source abstract
-
- ASO Visual Abstract: How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers?
- Garstka M, Henriquez A, Kelly BN, Webster A, Khubchandani JA, Hughes K, Nguyen A, Oseni T, Specht M, Coopey SB, Gadd MA, Smith BL.
- Ann Surg Oncol. 2021 Dec;28(Suppl 3):594-595. doi: 10.1245/s10434-021-10583-0.
- PMID: 34374912
- PubMed abstract
- Source abstract
-
- Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
- Yang Y, Pan L, Shao Z.
- Breast Cancer Res Treat. 2021 Dec;190(3):503-515. doi: 10.1007/s10549-021-06397-z. Epub 2021 Sep 23.
- PMID: 34554371
- PubMed abstract
- Source abstract
-
- Bilateral DIEP flap breast reconstruction with simultaneous unilateral nipple-sparing mastectomy - case report.
- Lukasz U, Piotr G, Maria M.
- Folia Med Cracov. 2021 Sep 29;61(3):115-124. doi: 10.24425/fmc.2021.138955.
- PMID: 34882668
- PubMed abstract
- Journal
-
- Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis.
- Jia Z, Li J, Zhang Y, Wang X, Xing J, Xing Z, Huang X, Liu G, Zhang M, Feng K, Wu J, Wang W, Wang J, Liu J, Wang X.
- Cancer Cell Int. 2021 Sep 25;21(1):512. doi: 10.1186/s12935-021-02194-2.
- PMID: 34563200
- PubMed abstract
-
- Chirurgie de réduction de risque mammaire et découverte fortuite de cancer : dix ans d’expérience dans un centre de lutte contre le cancer [Prophylactic mastectomy and occult cancer: a ten-year experience at a cancer center].
- Mangiardi-Veltin M, Chamming's F, Jaffre A, Rousvoal A, Tunon de Lara C, Brouste V, Hoppe S, Sénéchal C.
- Bull Cancer. 2021 Sep 20:S0007-4551(21)00298-8. French. doi: 10.1016/j.bulcan.2021.05.007. Epub ahead of print.
- PMID: 34556291
- PubMed abstract
- Source abstract
-
- Contralateral prophylactic mastectomy in the setting of breast cancer diagnosis and their insurance coverage in the United States.
- Ha M, Ngaage LM, Klein M, Yang A, Colohan SM, Nurudeen SM, Terhune JH, Slezak S, Rasko YM.
- Breast J. 2021 Sep 15. doi: 10.1111/tbj.14280. Epub ahead of print.
- PMID: 34528334
- PubMed abstract
- Source abstract
-
- Surgical management of BRCA pathogenic variant carriers with breast cancer: a recent literature review and current state of the art.
- Terribile DA, Mason EJ, Murando F, DI Leone A, Sanchez AM, Scardina L, Magno S, Franco A, D'Archi S, Natale M, Lucci Cordisco E, Masetti R, Franceschini G.
- Minerva Surg. 2021 Aug 2. doi: 10.23736/S2724-5691.21.09009-2. Epub ahead of print.
- PMID: 34338470
- PubMed abstract
- Source abstract
-
- Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients.
- Woo J, Gwak G, Park I, Bae BN, Lee SK, Chae BJ, Yu J, Lee JE, Kim SW, Nam SJ, Ryu JM.
- Sci Rep. 2021 Jul 20;11(1):14747. doi: 10.1038/s41598-021-94195-4.
- PMID: 34285295
- PubMed abstract
-
- Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer.
- Singareeka Raghavendra A, Alameddine HF, Andersen CR, Selber JC, Brewster AM, Barcenas CH, Caudle AS, Arun BK, Tripathy D, Ibrahim NK.
- Cancers (Basel). 2021 Apr 23;13(9):2050. doi: 10.3390/cancers13092050.
- PMID: 33922702
- PubMed abstract
- Source abstract
-
- Management of patients with BRCA mutation from the point of view of a breast surgeon.
- Riis ML.
- Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311.
- PMID: 33996049
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
- Scheepens JCC, van 't Veer L, Esserman L, Belkora J, Mukhtar RA.
- Breast. 2021 Apr;56:61-69. doi: 10.1016/j.breast.2021.02.003. Epub 2021 Feb 10.
- PMID: 33621798
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Delayed unilateral hematoma after reconstructive and aesthetic breast surgery with implants in Asian patients: two case reports.
- Lee JH, Hong HK, Kim WH, Kim HJ, Lee J, Park HY, Yang JD, Lee JS.
- Gland Surg. 2021 Apr;10(4):1515-1522. doi: 10.21037/gs-20-854.
- PMID: 33968703
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Contralateral Prophylactic Mastectomy in Patients with Breast Cancer.
- Noditi A, Caragheorghe G, Stoleru S, Blidaru A, Bordea CI.
- Chirurgia (Bucur). 2021 Mar-Apr;116(2 Suppl):73-83.
- PMID: 33963696
- PubMed abstract
- Source abstract
-
- Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.
- Kanana N, Ben David MA, Nissan N, Yagil Y, Shalmon A, Halshtok O, Gotlieb M, Faermann R, Klang E, Samoocha D, Yassin M, Davidson T, Zippel D, Madorsky Feldman D, Friedman E, Kaidar-Person O, Sklair Levy M.
- Breast J. 2021 Feb 11. doi: 10.1111/tbj.14190. Epub ahead of print.
- PMID: 33576117
- PubMed abstract
- Source abstract
-
- The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer.
- Basu NN, Hodson J, Chatterjee S, Gandhi A, Wisely J, Harvey J, Highton L, Murphy J, Barnes N, Johnson R, Barr L, Kirwan CC, Howell S, Baildam AD, Howell A, Evans DG.
- Sci Rep. 2021 Feb 2;11(1):2847. doi: 10.1038/s41598-021-82654-x.
- PMID: 33531640
- PubMed abstract
-
- A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
- Inuzuka M, Watanabe C, Yokoyama S, Kuwayama T, Akashi-Tanaka S, Arai M, Nakamura S; Registration Committee of the Japanese HBOC consortium.
- Clin Breast Cancer. 2021 Feb;21(1):e48-e52. doi: 10.1016/j.clbc.2020.08.004. Epub 2020 Aug 20.
- PMID: 32928640
- PubMed abstract
- Source abstract
-
- Challenges and Considerations on Risk-Reducing Surgery in BRCA1/2 Patients with Advanced Breast Cancer.
- Vasconcelos de Matos L, Fernandes L, Louro P, Plácido A, Barros M, Vaz F.
- Curr Oncol. 2021 Jan 14;28(1):485-490. doi: 10.3390/curroncol28010050.
- PMID: 33466630
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- Breast reconstruction in patients with BRCA mutation and breast cancer - our approach.
- Ventruba Tomáš, Brancíková Dagmar, Ventruba Pavel, Minár Luboš, Felsinger Michal, Vomela Jindrich.
- Ceska Gynekol. 2021;86(6):374-380. English. doi: 10.48095/cccg2021374.
- PMID: 35038874
- PubMed abstract
- Source abstract
-
- Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique.
- Toh U, Takenaka M, Iwakuma N, Akagi Y.
- Surg Today. 2020 Nov 13. doi: 10.1007/s00595-020-02175-4. Epub ahead of print.
- PMID: 33185799
- PubMed abstract
- Review
- Free Full Text
-
- Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns: A Long-Term Follow-Up Study of Koreans.
- Kim H, Choi DH, Park W.
- Medicina (Kaunas). 2020 Oct 1;56(10):E514. doi: 10.3390/medicina56100514.
- PMID: 33019612
- PubMed abstract
- Source abstract
-
- Quality of Life after Bilateral and Contralateral Prophylactic Mastectomy with Implant Reconstruction.
- Klapdor R, Weiß C, Kuehnle E, Kohls F, von Ehr J, Philippeit A, Hille-Betz U.
- Breast Care (Basel). 2020 Oct;15(5):519-526. doi: 10.1159/000505449. Epub 2020 Jan 24.
- PMID: 33223996
- PubMed abstract
- Source abstract
-
- Robot-assisted Nipple-sparing Mastectomy with Immediate Breast Reconstruction: An Initial Experience of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG).
- Ryu JM, Kim JY, Choi HJ, Ko BS, Kim J, Cho J, Lee MH, Choi JE, Kim JH, Lee J, Jung SM, Shin HJ, Lee J, Park HS.
- Ann Surg. 2020 Sep 15. doi: 10.1097/SLA.0000000000004492. Epub ahead of print.
- PMID: 32941285
- PubMed abstract
- Source abstract
-
- [In Situ Ductal Carcinoma with Hereditary Breast and Ovarian Cancer Syndrome in a Patient Who Received Contralateral Risk-Reducing Mastectomy-A Case Report].
- Kosaka Y, Kikuchi M, Nishimiya H, Katoh H, Kawaguchi R, Araki N, Shimazu M, Tsumura H, Waraya M, Takada F, Sengoku N, Sangai T.
- Gan To Kagaku Ryoho. 2020 Sep;47(9):1387-1389. Japanese.
- PMID: 33130707
- PubMed abstract
- Source abstract
-
- Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
- Murphy BL, Yi M, Arun BK, Gutierrez Barrera AM, Bedrosian I.
- Ann Surg Oncol. 2020 Jul 27. doi: 10.1245/s10434-020-08889-6. Epub ahead of print.
- PMID: 32720048
- PubMed abstract
- Source abstract
-
- ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer.
- Trombetta MG, Dragun A, Mayr NA, Pierce LJ.
- Pract Radiat Oncol. 2020 Jul-Aug;10(4):235-242. doi: 10.1016/j.prro.2020.04.003. Epub 2020 May 21.
- PMID: 32471709
- PubMed abstract
- Guideline, Review
- Free Full Text
Guideline:
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
- PMID: 32243226
- PubMed abstract
- Free Full Text
-
- Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
- Tung NM, Boughey JC, Pierce LJ, Robson ME, Bedrosian I, Dietz JR, Dragun A, Gelpi JB, Hofstatter EW, Isaacs CJ, Jatoi I, Kennedy E, Litton JK, Mayr NA, Qamar RD, Trombetta MG, Harvey BE, Somerfield MR, Zakalik D.
- J Clin Oncol. 2020 Jun 20;38(18):2080-2106. doi: 10.1200/JCO.20.00299. Epub 2020 Apr 3.
- PMID: 32243226
- PubMed abstract
- Source abstract
- Guideline
- Free Full Text
Summary, Review:
Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline.
- PMID: 32246307
- PubMed abstract
- Free Full Text
Summary, Review:
ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer.
- PMID: 32471709
- PubMed abstract
- Free Full Text
Commentary, Review:
Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations.
- PMID: 35717518
- PubMed abstract
- Free Full Text
-
- Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
- Allué Cabañuz M, Domingo Bretón M, Chóliz Ezquerro J, Arribas Del Amo MD, Güemes Sánchez AT.
- Cir Esp. 2020 Jun 3:S0009-739X(20)30115-9. English, Spanish. doi: 10.1016/j.ciresp.2020.04.008. Epub ahead of print.
- PMID: 32505558
- PubMed abstract
- Source abstract
-
- Risk Management for BRCA1/BRCA2 mutation carriers without and with breast cancer.
- Mainor CB, Isaacs C.
- Curr Breast Cancer Rep. 2020 Jun;12(2):66-74. doi: 10.1007/s12609-019-00350-2. Epub 2020 Feb 17.
- PMID: 33552388
- PubMed abstract
- Source abstract
-
- Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.
- Giardiello D, Hauptmann M, Steyerberg EW, Adank MA, Akdeniz D, Blom JC, Blomqvist C, Bojesen SE, Bolla MK, Brinkhuis M, Chang-Claude J, Czene K, Devilee P, Dunning AM, Easton DF, Eccles DM, Fasching PA, Figueroa J, Flyger H, García-Closas M, Haeberle L, Haiman CA, Hall P, Hamann U, Hopper JL, Jager A, Jakubowska A, Jung A, Keeman R, Koppert LB, Kramer I, Lambrechts D, Le Marchand L, Lindblom A, Lubinski J, Manoochehri M, Mariani L, Nevanlinna H, Oldenburg HSA, Pelders S, Pharoah PDP, Shah M, Siesling S, Smit VTHBM, Southey MC, Tapper WJ, Tollenaar RAEM, van den Broek AJ, van Deurzen CHM, van Leeuwen FE, van Ongeval C, Van't Veer LJ, Wang Q, Wendt C, Westenend PJ, Hooning MJ, Schmidt MK.
- Breast Cancer Res Treat. 2020 Apr 11. doi: 10.1007/s10549-020-05611-8. [Epub ahead of print]
- PMID: 32279280
- PubMed abstract
- Source abstract
-
- Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States.
- Yao K, Bleicher R, Moran M, Chang C, Dietz J, Stearns V, Connolly J, Sarantou T, Kurtzman S; National Accreditation Program for Breast Centers Data Working Group.
- Cancer Med. 2020 Mar 11. doi: 10.1002/cam4.2914. [Epub ahead of print]
- PMID: 32159280
- PubMed abstract
- Source abstract
-
- Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation.
- Teoh V, Tasoulis MK, Gui G.
- Cancers (Basel). 2020 Jan 6;12(1). pii: E140. doi: 10.3390/cancers12010140.
- PMID: 31935898
- PubMed abstract
- Source abstract
- Review
- Free full text
-
- Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
- Tynan M, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R, Hooker G, O'Neill SC, Jandorf L, Kelly SP, Heinzmann J, Kelleher S, Poggi E, Schwartz MD.
- Breast Cancer Res Treat. 2020 Jan 1. doi: 10.1007/s10549-019-05515-2. [Epub ahead of print]
- PMID: 31894446
- PubMed abstract
- Source abstract
-
- Trends in Contralateral Prophylactic Mastectomy.
- Fairbairn K, Cervantes A, Rayhrer C, Steen S.
- Aesthetic Plast Surg. 2019 Dec 18. doi: 10.1007/s00266-019-01582-4. [Epub ahead of print]
- PMID: 31853610
- PubMed abstract
- Source abstract
-
- Prediction and clinical utility of a contralateral breast cancer risk model.
- Giardiello D, Steyerberg EW, Hauptmann M, Adank MA, Akdeniz D, Blomqvist C, Bojesen SE, Bolla MK, Brinkhuis M, Chang-Claude J, Czene K, Devilee P, Dunning AM, Easton DF, Eccles DM, Fasching PA, Figueroa J, Flyger H, García-Closas M, Haeberle L, Haiman CA, Hall P, Hamann U, Hopper JL, Jager A, Jakubowska A, Jung A, Keeman R, Kramer I, Lambrechts D, Le Marchand L, Lindblom A, Lubiński J, Manoochehri M, Mariani L, Nevanlinna H, Oldenburg HSA, Pelders S, Pharoah PDP, Shah M, Siesling S, Smit VTHBM, Southey MC, Tapper WJ, Tollenaar RAEM, van den Broek AJ, van Deurzen CHM, van Leeuwen FE, van Ongeval C, Van't Veer LJ, Wang Q, Wendt C, Westenend PJ, Hooning MJ, Schmidt MK.
- Breast Cancer Res. 2019 Dec 17;21(1):144. doi: 10.1186/s13058-019-1221-1.
- PMID: 31847907
- PubMed abstract
-
- Is prophylactic mastectomy justified in women without BRCA mutation?
- Rutgers EJT.
- Breast. 2019 Nov;48 Suppl 1:S62-S64. doi: 10.1016/S0960-9776(19)31126-9.
- PMID: 31839163
- PubMed abstract
- Review
- Free Full Text
-
- Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction.
- Nealon KP, Sobti N, Gadd M, Specht M, Liao EC.
- Breast Cancer Res Treat. 2019 Oct 11. doi: 10.1007/s10549-019-05460-0. [Epub ahead of print]
- PMID: 31605310
- PubMed abstract
-
- Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status.
- Jeon HJ, Park HS, Park JS, Nam EJ, Lee ST, Han J.
- Ann Surg Treat Res. 2019 Sep;97(3):113-118. doi: 10.4174/astr.2019.97.3.113. Epub 2019 Aug 29.
- PMID: 31508390
- PubMed abstract
- Source abstract
-
- Hereditary breast cancer: screening and risk reducing surgery.
- Renzulli M, Zanotti S, Clemente A, Mineo G, Tovoli F, Reginelli A, Barile A, Cappabianca S, Taffurelli M, Golfieri R.
- Gland Surg. 2019 Sep;8(Suppl 3):S142-S149. doi: 10.21037/gs.2019.04.04.
- PMID: 31559181
- PubMed abstract
- Source abstract
-
- Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
- Terkelsen T, Rønning H, Skytte AB.
- Acta Oncol. 2019 Aug 5:1-6. doi: 10.1080/0284186X.2019.1648860. [Epub ahead of print]
- PMID: 31379231
- PubMed abstract
- Source abstract
-
- Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
- Franceschini G, Di Leone A, Masetti R.
- Patient Educ Couns. 2019 Aug;102(8):1573-1574. doi: 10.1016/j.pec.2019.03.006. Epub 2019 Mar 15.
- PMID: 30905494
- PubMed abstract
- Source abstract
-
- Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
- Bercow AS, Eisenhauer EL.
- J Surg Oncol. 2019 Jul 29. doi: 10.1002/jso.25645. [Epub ahead of print]
- PMID: 31355450
- PubMed abstract
- Source abstract
-
- Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.
- Grinstein O, Krug B, Hellmic M, Siedek F, Malter W, Burke C, Schmutzler R, Maintz D, Rhiem K.
- Surg Oncol. 2019 Jun;29:126-133. doi: 10.1016/j.suronc.2019.04.009. Epub 2019 May 3.
- PMID: 31196476
- PubMed abstract
- Source abstract
-
- Body image problems in women with and without breast cancer 6-20 years after bilateral risk-reducing surgery - A prospective follow-up study.
- Bai L, Arver B, Johansson H, Sandelin K, Wickman M, Brandberg Y.
- Breast. 2019 Apr;44:120-127. doi: 10.1016/j.breast.2019.01.013. Epub 2019 Feb 1.
- PMID: 30743225
- PubMed abstract
- Source abstract
-
- Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
- Evron E, Ben-David AM, Goldberg H, Fried G, Kaufman B, Catane R, Pfeffer MR, Geffen DB, Chernobelsky P, Karni T, Abdah-Bortnyak R, Rosengarten O, Matceyevsky D, Inbar M, Kuten A, Corn BW.
- Ann Oncol. 2019 Mar 1;30(3):412-417. doi: 10.1093/annonc/mdy515.
- PMID: 30475942
- PubMed abstract
- Source abstract
Editorial:
Is bilateral radiation an option for BRCA mutation carriers with unilateral breast cancer?
- PMID: 31168446
- PubMed abstract
- Free Full Text
-
- Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities.
- Bloom DL, Chapman BM, Wheeler SB, McGuire KP, Lee CN, Weinfurt K, Rosenstein DL, Plichta JK, Jacobson Vann JC, Hwang ES.
- Psychooncology. 2019 Feb;28(2):394-400. doi: 10.1002/pon.4955. Epub 2018 Dec 28.
- PMID: 30500102
- PubMed abstract
- Source abstract
-
- Helping Patients Manage the Anxiety Behind Contralateral Prophylactic Mastectomy.
- Schapira L, Parker P.
- Medscape. Medscape Oncology. 2019 Jan 17.
- Press, Interview
- Free Full Text
Original research:
Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.
- PMID: 30044695
- PubMed abstract
- Source abstract
-
- Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
- Yoshimura A, Okumura S, Sawaki M, Hattori M, Ishiguro J, Adachi Y, Kotani H, Gondo N, Kataoka A, Iwase M, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Takaiso N, Hyodo I, Iwata H.
- Breast Cancer. 2018 Sep;25(5):539-546. doi: 10.1007/s12282-018-0850-z. Epub 2018 Mar 8.
- PMID: 29520501
- PubMed abstract
- Source abstract
-
- Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.
- Elmi M, Sequeira S, Azin A, Elnahas A, McCready DR, Cil TD.
- Breast Cancer Res Treat. 2018 Sep;171(2):427-434. doi: 10.1007/s10549-018-4830-y. Epub 2018 May 28.
- PMID: 29808286
- PubMed abstract
- Source abstract
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Prophylactic mastectomy for the prevention of breast cancer: Review of the literature.
- Alaofi RK, Nassif MO, Al-Hajeili MR.
- Avicenna J Med. 2018 Jul-Sep;8(3):67-77. doi: 10.4103/ajm.AJM_21_18.
- PMID: 30090744
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Risk-reducing mastectomy for the prevention of primary breast cancer.
- Carbine NE, Lostumbo L, Wallace J, Ko H.
- Cochrane Database Syst Rev. 2018 Apr 5;4:CD002748. doi: 10.1002/14651858.CD002748.pub4.
- PMID: 29620792
- PubMed abstract
- Source abstract
Summary: Women should be aware of their true risk of developing breast cancer and the limitations of current evidence when considering risk-reducing mastectomy. (Cochrane Library)
-
- Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.
- Müller D, Danner M, Rhiem K, Stollenwerk B, Engel C, Rasche L, Borsi L, Schmutzler R, Stock S.
- Eur J Health Econ. 2018 Apr;19(3):341-353. doi: 10.1007/s10198-017-0887-5. Epub 2017 Apr 5.
- PMID: 28382503
- PubMed abstract
- Source abstract
-
- Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
- Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V, McLaughlin SA, Tchou JC, Vierkant RA, Degnim AC, Willey S.
- JAMA Surg. 2018 Feb 1;153(2):123-129. doi: 10.1001/jamasurg.2017.3422.
- PMID: 28903167
- PubMed abstract
- Source abstract
Commentary:
When is a Little Breast Tissue Too Much?: Nipple-Sparing Risk-Reducing Mastectomy in BRCA Carriers.
- PMID: 28903136
- PubMed abstract
- Source abstract
-
- The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study.
- Câmara S, Pereira D, André S, Mira B, Vaz F, Oom R, Marques JC, Leal de Faria J, Rodrigues Dos Santos C.
- Int J Breast Cancer. 2018 Jan 1;2018:1426369. doi: 10.1155/2018/1426369. eCollection 2018.
- PMID: 29507815
- PubMed abstract
- Source abstract
-
- Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG.
- Soenderstrup IMH, Laenkholm AV, Jensen MB, Eriksen JO, Gerdes AM, Hansen TVO, Kruse TA, Larsen MJ, Pedersen IS, Rossing M, Thomassen M, Ejlertsen B.
- Acta Oncol. 2018 Jan;57(1):95-101. doi: 10.1080/0284186X.2017.1398415. Epub 2017 Nov 22.
- PMID: 29164974
- PubMed abstract
- Source abstract
-
- The psycho-social impact of contralateral risk reducing mastectomy (CRRM) on women: a rapid review.
- Collins K, Gee M, Clack A, Wyld L.
- Psychooncology. 2018 Jan;27(1):43-52. doi: 10.1002/pon.4448. Epub 2017 May 31.
- PMID: 28453892
- PubMed abstract
- Source abstract
-
- Prophylactic Surgery: For Whom, When and How?
- Mau C, Untch M.
- Breast Care (Basel). 2017 Dec;12(6):379-384. doi: 10.1159/000485830. Epub 2017 Dec 13.
- PMID: 29456469
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.
- Frey JD, Salibian AA, Schnabel FR, Choi M, Karp NS.
- Plast Reconstr Surg Glob Open. 2017 Nov 20;5(11):e1564. doi: 10.1097/GOX.0000000000001564. eCollection 2017 Nov.
- PMID: 29263966
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Determining the Oncologic Safety of Autologous Fat Grafting as a Reconstructive Modality: An Institutional Review of Breast Cancer Recurrence Rates and Surgical Outcomes.
- Cohen O, Lam G, Karp N, Choi M.
- Plast Reconstr Surg. 2017 Sep;140(3):382e-392e. doi: 10.1097/PRS.0000000000003576.
- PMID: 28841600
- PubMed abstract
- Source abstract
-
- Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
- Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F, Song DH, Staley AC, Wilke LG, Willey SC, Yao KA, Margenthaler JA.
- Ann Surg Oncol. 2016 Oct;23(10):3100-5. doi: 10.1245/s10434-016-5443-5. Epub 2016 Jul 28.
- PMID: 27469117
- PubMed abstract
- Practice Guideline
- Free PMC article
- Free Full Text
Clinical Guideline
Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making.
- PMID: 27469118
- PubMed abstract
News: Contralateral Prophylactic Mastectomy Discouraged: ASBrS (Medscape Oncology)
-
- Contralateral prophylactic mastectomy: current perspectives.
- Yao K, Sisco M, Bedrosian I.
- Int J Womens Health. 2016 Jun 22;8:213-23. doi: 10.2147/IJWH.S82816. eCollection 2016.
- PMID: 27382334
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?
- Freitas V, Crystal P, Kulkarni SR, Ghai S, Bukhanov K, Escallon J, Scaranelo AM.
- Cancer Med. 2016 Jun;5(6):1031-6. doi: 10.1002/cam4.663. Epub 2016 Mar 18.
- PMID: 26992816
- PubMed abstract
- Source abstract
-
- What is new in the surgical management and prevention of breast cancer?
- Spillane AJ.
- Med J Aust. 2016 May 2;204(8):311-4.
- PMID: 27125805
- PubMed abstract
- Review
- Free Full Text
-
- Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy.
- Yao K, Belkora J, Sisco M, Rosenberg S, Bedrosian I, Liederbach E, Wang C.
- JAMA Surg. 2016 Apr 1;151(4):391-3. doi: 10.1001/jamasurg.2015.3601.
- PMID: 26606424
- PubMed abstract
- Source abstract
-
- Is Sentinel Lymph Node Biopsy Necessary in Patients Undergoing Prophylactic Mastectomy? A Systematic Review and Meta-Analysis.
- Nagaraja V, Edirimanne S, Eslick GD.
- Breast J. 2016 Mar-Apr;22(2):158-65. doi: 10.1111/tbj.12549. Epub 2016 Jan 8.
- PMID: 26748493
- PubMed abstract
- Source abstract
-
- Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.
- Basu NN, Littlechild S, Barr L, Ross GL, Evans DG.
- Ann R Coll Surg Engl. 2016 Feb;98(2):121-7. doi: 10.1308/rcsann.2016.0039. Epub 2016 Jan 7.
- PMID: 26741657
- PubMed abstract
- Source abstract
-
- Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature.
- Flippo-Morton T, Walsh K, Chambers K, Amacker-North L, White B, Sarantou T, Boselli DM, White RL Jr.
- Breast J. 2016 Jan-Feb;22(1):35-44. doi: 10.1111/tbj.12521. Epub 2015 Dec 23.
- PMID: 26695813
- PubMed abstract
- Source abstract
-
- Breast Reconstruction Options.
- Kathy Steligo.
- FORCE. Be Empowered Webinars. 2015 Oct 19.
- Webinar
- Free video
-
- Personalization of loco-regional care for primary breast cancer patients (part 2).
- Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, Kunkler I, Ho AY, Yamauchi C, Chow LW, Huang CS, Han W, Noguchi S, Pegram MD, Yamauchi H, Lee ES, Larionov AA, Bevilacqua JL, Yoshimura M, Sugie T, Yamauchi A, Krop IE, Noh DY, Klimberg VS; 2014 Kyoto Breast Cancer Consensus Conference.
- Future Oncol. 2015 May;11(9):1301-5. doi: 10.2217/fon.15.66.
- PMID: 25952778
- PubMed abstract
- Source abstract
-
- Prophylactic Mastectomy Offers Minimal Gain in Breast Cancer.
- Miriam E. Tucker.
- Medscape Medical News. Conference News. American College of Surgeons (ACS) 2013 Annual Clinical Congress. 2013 Oct 8.
- Conference Report
- Free Full Text
-
- Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.
- Tracy MS, Rosenberg SM, Dominici L, Partridge AH.
- Breast Cancer Res Treat. 2013 Aug;140(3):447-52. doi: 10.1007/s10549-013-2643-6. Epub 2013 Jul 28.
- PMID: 23893127
- PubMed abstract
- Source abstract
- Review
- Free PMC article
-
- Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy.
- Musiello T, Bornhammar E, Saunders C.
- ANZ J Surg. 2013 Jul;83(7-8):527-32. doi: 10.1111/j.1445-2197.2012.06209.x. Epub 2012 Oct 8.
- PMID: 23043449
- PubMed abstract
- Source abstract
-
- [Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers].
- Bit-Sava EM, Belogurova MB, Imianitov EN, Balandov SG, Korniushin OV, Borisov MK.
- Vopr Onkol. 2013;59(2):5-11.
- PMID: 23814843
- PubMed abstract
-
- Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
- Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y.
- Cancer. 2012 Nov 15;118(22):5637-43. doi: 10.1002/cncr.27574. Epub 2012 Apr 19.
- PMID: 22517269
- PubMed abstract
- Source abstract
-
- Role of Breast Surgery in BRCA Mutation Carriers.
- Nestle-Krämling C, Kühn T.
- Breast Care (Basel). 2012 Oct;7(5):378-82. doi: 10.1159/000343717.
- PMID: 24647776
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text